Submitted by Nicola-Swanborough on Thu, 10/10/2019 - 16:07
Epilepsy Society has welcomed the news that 96 per cent of medicine suppliers in the UK have now responded to the Government about their preparations for exiting the European Union.
Submitted by Nicola-Swanborough on Mon, 23/09/2019 - 12:17
Epilepsy Society's Chief Executive Clare Pelham says she is pleased to learn that the Government has now signed up eight firms to help bring in vital medicines to the UK after Brexit on 31 October 2019
Submitted by Nicola-Swanborough on Thu, 12/09/2019 - 14:52
The Department of Health and Social Services (DHSC) has assured us they are doing everything they can to ensure an uninterrupted supply of medicines following Brexit on 31 October.
Submitted by rhiannon-arden on Thu, 04/07/2019 - 16:25
The All Party Parliamentary Group on Epilepsy is holding a meeting on 23 July about the effect of Brexit on epilepsy.
Submitted by Nicola-Swanborough on Thu, 27/06/2019 - 15:10
The Government has announced further measures to ensure there will be an uninterrupted supply of medicines if the UK leaves the European Union without a deal on 31 October.
Submitted by Nicola-Swanborough on Mon, 15/04/2019 - 18:25
Health minister Stephen Hammond MP responds to Epilepsy Society's call for more information about medicines shortages. Mr Hammond is replying on behalf of Health Secretary Matt Hancock.
Submitted by Nicola-Swanborough on Mon, 08/04/2019 - 18:45
A leading UK charity is calling on Health Secretary Matt Hancock to commission an urgent review of the medicines supply chain as patients are forced to trawl around pharmacies in search of their drugs.
Submitted by Nicola-Swanborough on Mon, 01/04/2019 - 12:10
Epilepsy Society's medical director Professor Ley Sander looks at the problems surrounding shortages of medications and explains what you can do to manage the situation and how the Government is tackling current shortages.
Submitted by Nicola-Swanborough on Fri, 18/01/2019 - 11:35
Epilepsy Society's medical director, Professor Ley Sander is advising people with epilepsy not to stockpile medication themselves.
In August 2018, the Government asked pharmaceutical companies to ensure they have a minimum six week stockpile of prescription-only and pharmacy-only medicines in case of potential delays at UK borders after Brexit on 31 October 2019.
We have contacted pharmaceutical companies in the UK to find out what their individual contingency plans are. Their responses are detailed in the table below.